GGrantIndex
Sort

17,828 grants matching crispr

CRISPR-inhibition for FSHD

$538,881
Peter L Jones · University Of Nevada Reno · R01 · FY2021 · AR

Systems Biology of Glycosylation

$538,813
Sriram Neelamegham · State University Of New York At Buffalo · R01 · FY2024 · HL

Chromatin Dynamics During Epithelial Commitment

$538,793
Anthony E Oro · Stanford University · R01 · FY2025 · AR

Role of S-nitrosylation in regulating cardiac function and disease

$538,722
Elizabeth Murphy · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL

Regulation of T cell memory in tissue immunity

$538,352
Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2025 · AI

Reovirus Neuropathogenesis

$538,059
Terence S. Dermody · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI

Sulfide metabolism and signaling

$537,906
Ruma V Banerjee · University Of Michigan At Ann Arbor · R35 · FY2024 · GM

Integrative Genomic Analyses of Human Evolution and Adaptation in Africa

$537,875
Sarah A Tishkoff · University Of Pennsylvania · R35 · FY2024 · GM

MYB family alterations in pediatric gliomas

$537,868
Keith L Ligon · Dana-Farber Cancer Inst · R01 · FY2019 · CA

Targeting SMARCA2 as a therapeutic strategy in SMARCA4 mutant lung cancer

$537,633
Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA

Targeting SMARCA2 as a therapeutic strategy in SMARCA4 mutant lung cancer

$537,633
Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

DNA repair alterations in metastatic prostate cancer: functional and therapeutic implications

$537,593
Alan Ashworth · University Of California, San Francisco · R01 · FY2020 · CA

The function of LIN28B and follistatin in supporting cell reprogramming and hair cell regeneration in the murine cochlea

$537,495
Angelika Doetzlhofer · Johns Hopkins University · R01 · FY2022 · DC

Mechanisms of Novel Regulators of Proteotoxicity and Quality Control Associated with ALS/FTD

$537,477
Jiou Wang · Johns Hopkins University · R01 · FY2022 · NS

Mechanisms of Novel Regulators of Proteotoxicity and Quality Control Associated with ALS/FTD

$537,477
Jiou Wang · Johns Hopkins University · R01 · FY2021 · NS

Modulating the adaptive immune response to enhance the efficiency of in vivo gene editing in muscle

$537,378
Thomas F Serwold · Joslin Diabetes Center · R01 · FY2025 · NS

Modulating the adaptive immune response to enhance the efficiency of in vivo gene editing in muscle

$537,378
Thomas F Serwold · Joslin Diabetes Center · R01 · FY2024 · NS

Structural and functional understanding of bacterial defense and viral counter defense

$537,366
Blake A Wiedenheft · Montana State University - Bozeman · R35 · FY2023 · GM

Structural and functional understanding of bacterial defense and viral counter defense

$537,366
Blake A Wiedenheft · Montana State University - Bozeman · R35 · FY2022 · GM

Structural and functional understanding of bacterial defense and viral counter defense

$537,366
Blake A Wiedenheft · Montana State University - Bozeman · R35 · FY2024 · GM

Modeling Susceptibility to Chemotherapy-Induced Cardiotoxicity Using Human iPSCs

$537,363
Joseph C Wu · Stanford University · R01 · FY2020 · HL

Unravelling Metabolic Plasticity Through Genetic Interaction Mapping.

$537,325
Michael Aregger · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

NHGRI Advanced Imaging & Analysis Core

$537,146
Stephen Wincovitch · National Human Genome Research Institute · ZIC · FY2025 · HG

A platform to functionally sort and analyze tumor cells within combinatorial metastatic micorenvironments

$537,134
David Kevin Wood · University Of Minnesota · R01 · FY2024 · CA

Developmentally Regulated Enhancers and Chromatin Architecture in Human Neurogenesis

$537,026
Dimitris G. Placantonakis · New York University School Of Medicine · R01 · FY2023 · NS